Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached global epidemic status claiming more than 319K lives and affecting more than 4.81M people and counting worldwide. Considering the severity of the situation and low recovery rate many research institutions and pharmaceutical...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Journal of Pure and Applied Microbiology
2020-05-01
|
| Series: | Journal of Pure and Applied Microbiology |
| Subjects: | |
| Online Access: | https://microbiologyjournal.org/current-clinical-trials-and-vaccine-development-strategies-for-corona-virus-disease-covid-19/ |
| _version_ | 1818569468913123328 |
|---|---|
| author | Abhi Bhadra Shweta Singh Shaswat Chandrakar Vanshika Kumar Sakshi Sankhla Sayuj Raj T. E. Selvarajan |
| author_facet | Abhi Bhadra Shweta Singh Shaswat Chandrakar Vanshika Kumar Sakshi Sankhla Sayuj Raj T. E. Selvarajan |
| author_sort | Abhi Bhadra |
| collection | DOAJ |
| description | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached global epidemic status
claiming more than 319K lives and affecting more than 4.81M people and counting worldwide.
Considering the severity of the situation and low recovery rate many research institutions and
pharmaceutical industries are rushing to learn more about this new virus and the morbid physiology
of this disease with effective diagnostic methods, therapeutic agents and vaccines. Various approaches
are highlighted for comparing the possible treatment methods available for COVID-19 some of which
are BCG vaccination on COVID-19 and Non-pharmaceutical interventions, drug based clinical trials of
Hydroxychloroquine-Azithromycin, chloroquine, lopinavir/ritonavir, ChAdOx1 nCoV-19, Remdesivir,
Stem Cell therapy and mesenchymal stromal cell therapy, etc. |
| first_indexed | 2024-12-14T06:48:32Z |
| format | Article |
| id | doaj.art-10d031ccaa0a41d085a517e54df1ac3e |
| institution | Directory Open Access Journal |
| issn | 0973-7510 2581-690X |
| language | English |
| last_indexed | 2024-12-14T06:48:32Z |
| publishDate | 2020-05-01 |
| publisher | Journal of Pure and Applied Microbiology |
| record_format | Article |
| series | Journal of Pure and Applied Microbiology |
| spelling | doaj.art-10d031ccaa0a41d085a517e54df1ac3e2022-12-21T23:12:58ZengJournal of Pure and Applied MicrobiologyJournal of Pure and Applied Microbiology0973-75102581-690X2020-05-0114suppl 197998810.22207/JPAM.14.SPL1.36Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19)Abhi Bhadra0https://orcid.org/0000-0003-0223-3206Shweta Singh1https://orcid.org/0000-0002-8790-9692Shaswat Chandrakar2https://orcid.org/0000-0001-9586-292XVanshika Kumar3https://orcid.org/0000-0002-3034-191XSakshi Sankhla4https://orcid.org/0000-0002-7759-3495Sayuj Raj T.5https://orcid.org/0000-0002-6439-5465E. Selvarajan6https://orcid.org/0000-0002-3447-6432Department of Genetic Engineering, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur - 603 203, Tamil Nadu, India.Department of Genetic Engineering, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur - 603 203, Tamil Nadu, India.Department of Genetic Engineering, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur - 603 203, Tamil Nadu, India.Department of Genetic Engineering, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur - 603 203, Tamil Nadu, India.Department of Genetic Engineering, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur - 603 203, Tamil Nadu, India.Department of Genetic Engineering, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur - 603 203, Tamil Nadu, India.Department of Genetic Engineering, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur - 603 203, Tamil Nadu, India.Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached global epidemic status claiming more than 319K lives and affecting more than 4.81M people and counting worldwide. Considering the severity of the situation and low recovery rate many research institutions and pharmaceutical industries are rushing to learn more about this new virus and the morbid physiology of this disease with effective diagnostic methods, therapeutic agents and vaccines. Various approaches are highlighted for comparing the possible treatment methods available for COVID-19 some of which are BCG vaccination on COVID-19 and Non-pharmaceutical interventions, drug based clinical trials of Hydroxychloroquine-Azithromycin, chloroquine, lopinavir/ritonavir, ChAdOx1 nCoV-19, Remdesivir, Stem Cell therapy and mesenchymal stromal cell therapy, etc.https://microbiologyjournal.org/current-clinical-trials-and-vaccine-development-strategies-for-corona-virus-disease-covid-19/lopinavirritonavirchloroquinehydroxychloroquinestem cell therapycytokinesremdesivir |
| spellingShingle | Abhi Bhadra Shweta Singh Shaswat Chandrakar Vanshika Kumar Sakshi Sankhla Sayuj Raj T. E. Selvarajan Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19) Journal of Pure and Applied Microbiology lopinavir ritonavir chloroquine hydroxychloroquine stem cell therapy cytokines remdesivir |
| title | Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19) |
| title_full | Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19) |
| title_fullStr | Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19) |
| title_full_unstemmed | Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19) |
| title_short | Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19) |
| title_sort | current clinical trials and vaccine development strategies for corona virus disease covid 19 |
| topic | lopinavir ritonavir chloroquine hydroxychloroquine stem cell therapy cytokines remdesivir |
| url | https://microbiologyjournal.org/current-clinical-trials-and-vaccine-development-strategies-for-corona-virus-disease-covid-19/ |
| work_keys_str_mv | AT abhibhadra currentclinicaltrialsandvaccinedevelopmentstrategiesforcoronavirusdiseasecovid19 AT shwetasingh currentclinicaltrialsandvaccinedevelopmentstrategiesforcoronavirusdiseasecovid19 AT shaswatchandrakar currentclinicaltrialsandvaccinedevelopmentstrategiesforcoronavirusdiseasecovid19 AT vanshikakumar currentclinicaltrialsandvaccinedevelopmentstrategiesforcoronavirusdiseasecovid19 AT sakshisankhla currentclinicaltrialsandvaccinedevelopmentstrategiesforcoronavirusdiseasecovid19 AT sayujrajt currentclinicaltrialsandvaccinedevelopmentstrategiesforcoronavirusdiseasecovid19 AT eselvarajan currentclinicaltrialsandvaccinedevelopmentstrategiesforcoronavirusdiseasecovid19 |